11:00 AM
 | 
Mar 16, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Arcus raises upsized $120M IPO

Arcus Biosciences Inc. (NYSE:RCUS) raised on March 14 $120 million through the sale of 8 million shares at $15 in an upsized IPO underwritten by Citigroup, Goldman Sachs and Leerink. The IPO price valued Arcus at $638.3 million; it ended the day with a market cap of $726.8 million.

On March 9, Arcus...

Read the full 241 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >